tiprankstipranks
Trending News
More News >
Savaria (TSE:SIS)
TSX:SIS
Advertisement

Savaria (SIS) AI Stock Analysis

Compare
405 Followers

Top Page

TSE:SIS

Savaria

(TSX:SIS)

Rating:79Outperform
Price Target:
C$24.00
▲(16.11% Upside)
Savaria's strong financial performance and positive earnings call are the most significant factors contributing to the stock's score. The company's robust revenue growth, profitability, and strategic initiatives position it well for future growth. Technical analysis supports a positive trend, although the valuation suggests the stock may be slightly overvalued. Challenges in Europe are noted but are expected to be temporary.

Savaria (SIS) vs. iShares MSCI Canada ETF (EWC)

Savaria Business Overview & Revenue Model

Company DescriptionSavaria Corporation (SIS) is a global leader in the accessibility industry, specializing in the design, manufacturing, and distribution of products that enhance mobility for people with physical challenges. The company operates in three primary sectors: Accessibility, Patient Handling, and Adapted Vehicles. Its core products and services include stairlifts, wheelchair lifts, home elevators, ceiling lifts, and adapted vehicles, catering to both residential and commercial markets.
How the Company Makes MoneySavaria Corporation generates revenue through the sale and distribution of its diverse range of accessibility and mobility products. The company has multiple revenue streams, primarily stemming from its Accessibility segment, which includes stairlifts, home elevators, and wheelchair lifts sold to private residences and commercial establishments. The Patient Handling segment contributes to revenue through the sale of ceiling lifts and slings used in healthcare facilities to safely transport patients. Additionally, the Adapted Vehicles segment provides customized vehicles for individuals with mobility impairments. Savaria's earnings are bolstered by a strategic network of dealers and distributors worldwide, ensuring a broad market reach. The company also benefits from partnerships with healthcare facilities and government programs that support accessibility initiatives, driving sales and expanding its market presence.

Savaria Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 05, 2025
Earnings Call Sentiment Positive
The earnings call highlighted Savaria's strong financial performance, particularly in achieving and surpassing margin targets, with significant operational improvements driven by the Savaria One program. However, there were challenges noted in specific regions and market conditions, particularly in Europe and the Accessibility segment, which impacted overall growth. Despite these challenges, the company remains optimistic about future growth potential driven by new product launches and ongoing strategic initiatives.
Q2-2025 Updates
Positive Updates
Achievement of High Margin
Savaria Corporation achieved a Q2 EBITDA margin of 20.6%, surpassing their 20% target, marking a new high for the company.
Strong Financial Metrics
Gross margin increased by 150 basis points year-over-year to 39%. Operating cash flows were up 28.4%, and net earnings increased to $16.3 million compared to $11.4 million last year.
Positive Cash Flow and Debt Reduction
Free cash flow after debt-related costs and dividends was $9.4 million for the quarter, a 204% increase compared to last year. The company also reduced its leverage ratio to 1.34.
Successful Product Launches
Savaria launched the M-Series ceiling lift, contributing to a strong backlog in Patient Care, and the Luma product, which is expected to drive future growth.
Savaria One Program Impact
The Savaria One initiative continues to drive operational efficiencies, contributing significantly to the improved margins and cash flow.
Negative Updates
Soft Growth in Accessibility Segment
Growth in the Accessibility segment was not as strong as desired, with a 1.9% increase overall and some contraction in Europe by 0.8%.
Challenges in Europe
Negative growth in Europe was attributed to government spending reductions in the UK and subsidy issues in Italy.
Temporary Market Challenges
Temporary market conditions affected growth, particularly in the Accessibility segment, although these are expected to be short-term.
Company Guidance
During Savaria Corporation's Q2 2025 conference call, the company provided guidance for the remainder of the year, projecting an EBITDA margin of approximately 20% and maintaining a sales target of around $925 million. The Q2 results highlighted a strong performance with a 20.6% EBITDA margin, bolstered by improvements in their Savaria One program. The Accessibility segment achieved a 21.9% margin, while Patient Care reached 20.9%. Despite a slight negative growth in Europe due to government spending issues and subsidy cutbacks, North America showed a year-to-date growth of 7.7%. Savaria plans to focus on new product launches, such as the Luma, and expanding dealer networks to stimulate growth. Additionally, the company's debt ratio improved to 1.34, with available funds of $275 million, positioning them well for future investments or acquisitions. The call also emphasized continued efforts in R&D and the importance of maintaining pricing discipline to support sustainable growth.

Savaria Financial Statement Overview

Summary
Savaria demonstrates robust financial performance with solid revenue growth, healthy profit margins, and efficient cash flow generation. The income statement shows consistent revenue growth and improved net profit margin. The balance sheet reflects a stable financial position with manageable leverage, and cash flow analysis indicates strong cash generation.
Income Statement
85
Very Positive
Savaria's income statement shows solid performance with consistent revenue growth. Revenue grew by 1.25% from the previous year to TTM, and the net profit margin improved to 5.68% in the TTM from 5.59% in the previous year. The gross profit margin stood at 37.51% in the TTM, indicating strong pricing power and cost management. EBIT and EBITDA margins also showed healthy levels at 9.98% and 15.90%, respectively, demonstrating operational efficiency.
Balance Sheet
78
Positive
The balance sheet reflects a stable financial position with a reasonable debt-to-equity ratio of 0.48, indicating manageable leverage. The equity ratio of 52.68% in the TTM suggests a well-capitalized structure. Return on equity improved to 8.44% in the TTM, highlighting effective use of equity capital. However, total debt levels, although declining, remain significant and should be monitored.
Cash Flow
80
Positive
Cash flow analysis reveals healthy cash generation with a consistent operating cash flow to net income ratio of 2.42 in the TTM, suggesting effective conversion of income to cash. Free cash flow to net income ratio stands at 2.00, indicating strong free cash flow generation. Free cash flow growth was stable, with a slight increase from the previous year, supporting capital expenditure needs and potential for shareholder returns.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue883.95M867.76M836.95M789.09M660.98M354.50M
Gross Profit335.08M321.71M286.02M254.37M215.54M122.13M
EBITDA145.86M136.58M123.82M99.25M82.70M55.98M
Net Income55.30M48.51M37.84M35.31M11.54M26.46M
Balance Sheet
Total Assets1.12B1.11B1.10B1.11B1.11B453.31M
Cash, Cash Equivalents and Short-Term Investments38.91M35.24M54.27M44.73M63.49M54.18M
Total Debt265.12M292.62M319.38M410.07M432.34M78.05M
Total Liabilities508.06M538.94M552.57M656.99M672.32M173.58M
Stockholders Equity613.50M575.27M549.00M452.97M434.60M279.73M
Cash Flow
Free Cash Flow114.91M99.95M59.76M70.22M41.56M42.33M
Operating Cash Flow131.53M120.10M78.62M90.74M57.28M49.31M
Investing Cash Flow-19.45M-20.63M-6.36M-21.58M-396.44M-7.38M
Financing Cash Flow-116.08M-118.00M-63.11M-83.25M351.80M-27.32M

Savaria Technical Analysis

Technical Analysis Sentiment
Positive
Last Price20.67
Price Trends
50DMA
20.15
Positive
100DMA
19.25
Positive
200DMA
18.85
Positive
Market Momentum
MACD
0.13
Positive
RSI
52.31
Neutral
STOCH
22.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:SIS, the sentiment is Positive. The current price of 20.67 is below the 20-day moving average (MA) of 20.88, above the 50-day MA of 20.15, and above the 200-day MA of 18.85, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 52.31 is Neutral, neither overbought nor oversold. The STOCH value of 22.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:SIS.

Savaria Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
C$1.48B26.679.45%2.61%3.06%19.32%
64
Neutral
$10.73B15.747.63%2.01%2.75%-15.09%
46
Neutral
C$335.66M-26.06%0.19%-5.20%-658.62%
40
Underperform
C$3.74B38.53-2.31%-13.38%-122.14%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:SIS
Savaria
20.67
0.97
4.92%
TSE:ATS
ATS Corporation
38.25
2.68
7.53%
TSE:VLN
Velan Inc. SV
15.55
9.41
153.26%

Savaria Corporate Events

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Savaria Achieves Record Earnings and Strategic Growth in Q2 2025
Positive
Aug 6, 2025

Savaria Corporation reported a record second quarter in 2025, with net earnings of $16.3 million and an adjusted EBITDA margin of 20.6%. The company’s revenue increased by 2.4% to $226.7 million, driven by favorable foreign exchange rates and the acquisition of Western Elevator, despite a slight organic contraction. The company achieved significant growth in its Patient Care segment and improved gross profit margins, reflecting operational efficiencies. With available funds of $275.5 million, Savaria is well-positioned for future investments and growth, including the expansion of its product offerings and strategic acquisitions.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Savaria Corporation Achieves Record Earnings and Growth in Q2 2025
Positive
Aug 6, 2025

Savaria Corporation reported a record second quarter in 2025, with net earnings of $16.3 million and an adjusted EBITDA margin of 20.6%. The company’s revenue increased by 2.4% to $226.7 million, driven by favorable foreign exchange rates and the acquisition of Western Elevator. The accessibility segment, which accounts for 78% of the company’s revenue, grew by 1.9%, while the patient care segment saw a 4.4% increase. Savaria’s strategic focus on operational efficiencies and market expansion, including a new production line in South Carolina and marketing initiatives for new products, positions it well for future growth.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Financial Disclosures
Savaria to Release Q2 2025 Financial Results
Neutral
Jul 28, 2025

Savaria Corporation announced it will release its second quarter 2025 financial results on August 6, 2025, followed by an investor conference call on August 7, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the accessibility industry.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Dividends
Savaria Corporation Announces Monthly Dividend for August 2025
Positive
Jul 23, 2025

Savaria Corporation has announced a monthly dividend of 4.5 cents per common share, payable on August 11, 2025, to shareholders of record as of July 31, 2025. This dividend declaration aligns with the company’s policy and reflects its stable financial performance, potentially reinforcing investor confidence and solidifying its position in the accessibility market.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Dividends
Savaria Corporation Announces Monthly Dividend for Shareholders
Positive
Jun 20, 2025

Savaria Corporation has announced a monthly dividend of 4.5 cents per common share, payable on July 9, 2025, to shareholders of record as of June 30, 2025. This declaration aligns with Savaria’s ongoing commitment to providing shareholder value and reflects its stable financial performance in the accessibility industry.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$24.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Dividends
Savaria Corporation Announces Monthly Dividend for Shareholders
Positive
May 22, 2025

Savaria Corporation has announced a monthly dividend of 4.5 cents per common share, payable on June 9, 2025, to shareholders of record as of May 30, 2025. This declaration aligns with the company’s dividend policy and reflects its commitment to returning value to shareholders, potentially enhancing its attractiveness to investors in the accessibility industry.

The most recent analyst rating on (TSE:SIS) stock is a Buy with a C$23.00 price target. To see the full list of analyst forecasts on Savaria stock, see the TSE:SIS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025